Navigation Links
First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Date:9/5/2007

demic Network, LLC: Academic Network, LLC is a leading medical and health communications company conceived by academic professionals to serve as a singular source for communicating health-related issues to consumers and health professionals. Academic Network works with leading pharmaceutical companies, healthcare organizations and food/beverage companies in developing effective communications strategies through consulting, telecommunications internet and other public media sources. The firm offers the combined technological and medical expertise necessary to meet the demands and expectations of today's health-focused public.

Contact: Claudia Johnson

Claudia@claudiajohnson.com

503.266.1776

Or

Rachel Greben

rgreben@academicnetwork.com

503.228.3217


'/>"/>
SOURCE Academic Network, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Massive Booking For Chinas First-Ever Five-Star Hospital
2. Europeans Developing First-Ever Dengue Fever Vaccine
3. First-Ever Robotic Pancreatectomy Performed at UIC
4. South Africa Notes Signs of First-ever Decline in HIV Infection Rates
5. Drugs Kill 15,000 Indonesians Every Year
6. Rare Disease Prompts Culling of 15,000 birds
7. RNIB Receives ?25,000 to Help Blin
8. 25,000 Needless Deaths Each Year Due to Failure to Tackle Blood Clots in Hospital
9. Australian Businesses Prepare for Outbreak of Bird Flu
10. Autopsy reports could be valuable and informative
11. China reports declining number of SARS Cases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., PALO ALTO, Calif., Dec. 4 /PRNewswire-FirstCa...nced today that its Board of Directors has set the...ebruary 11, 2010 with a record date of December 16...za Cabana Hotel, 4290 El Camino Real, Palo Alto, C...be webcast by Thomson Financial and can be accesse...
(Date:12/4/2009)...YORK, Dec. 4 Care Inves...ompany") today announced that its Board of Directo...ommon stock. The dividend is payable on December ...ber 14, 2009. ,, About Care Investment Trus...te investment and finance company investing in hea...
(Date:12/4/2009)...EW YORK, Dec. 4 Thousands of KPMG ...s nationwide today, to participate in a community ...visory firm,s support for literacy with charitable...s our firm,s long history of volunteerism. Instead... spirit of caring to brighten the holidays for som...
(Date:12/4/2009)...N FRANCISCO, Dec. 4 Medithrive, In...ite dispensary in the SF Bay Area by popular vote .... Despite only three months in operation, the SF ...inent location for accessing medicinal marijuana. ...e confirms the obvious: a dispensary which caters ...
(Date:12/4/2009)... PEMBROKE, Bermuda, Dec. 4 /PRNewswire-FirstCall...(NYSE: AWH ) today announced that Scott Carmilan... Sennott, Executive Vice,President and Chief Corpo...009,Goldman Sachs U.S. Financial Services Conferen...er in New York City on Tuesday, December 8, 2009. ...
Breaking Medicine News(10 mins):Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
...arch presented at Digestive Disease Week 2005, ant...l bleedings. Clinical depression, also known ...depressant drugs like selective serotonin reuptake...leeding and hemorrhage in gastro intestinal tracts...
...rom Wake Forest University Baptist Medical Center,...orks equally well for children with cancer, and th... The researchers had looked into the chemothe...ery limited dosage of chemotherapy and were monito...
...ering from Attention Deficit Hyperactivity Syndrom...n with the help of sensory interventions like appl...us exercise, etc. Attention Deficit Hyperacti...to be impulsive, inattentive and hyperactive. Rece...
...ave identified a virus that targets and kills a ty...omatitis virus (VSV) can successfully target and k...rms of brain tumors. Glioblastoma is a form of bra...viruses through a series of tests to find out the ...
...rom Netherlands have found out that certain ordina...l drugs can cause deaths from cardiac arrest. ...n Heart Journal, said that the non-cardiac drugs i...rolong the duration of electrical activity that co...
... report done by Swedish scientists its said that i...ge of prostate cancer than to wait and see if the ...tate cancer, also known as prostatectomy, is a com...watching and waiting the cancer in the prostate gl...
Other Medicine News:
(Date:12/4/2009)...RISTOWN, N.J., Dec. 4 Wa...ng global specialty pharmaceutical company, today ..., Inc.-Florida, filed an Abbreviated New Drug Appl...tration seeking approval to market its 8mg ramelte...ed by Takeda Pharmaceutical Company Limited. Wats...
(Date:12/4/2009)...SDA, Md., Dec. 4 Drs. Neal Shore a...e-specific antigen (PSA) recurrence from the addit...cal recurrence rate in a Phase III pivotal study o... or monthly leuprolide in prostate cancer patients...cer patients who received FIRMAGON 240/80 mg/month...
(Date:12/4/2009)...INGTON, Del., Dec. 4 Ast...S Food and Drug Administration (FDA) has approved ... Extended Release Tablets as adjunctive (add-on) t...epressive Disorder (MDD). SEROQUEL XR is the only ...at both major depressive disorder as adjunctive th...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient Centered Care Initiatives 53960 1Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient Centered Care Initiatives 53960 2Steroid Can Ease Severe Sore Throat 53956 1Steroid Can Ease Severe Sore Throat 53956 2Steroid Can Ease Severe Sore Throat 53956 3Allscripts Notified of Purported Class Action Lawsuit 53952 1Allscripts Notified of Purported Class Action Lawsuit 53952 2Allscripts Notified of Purported Class Action Lawsuit 53952 3
...ells Inc. (BCI), a,biopharmaceutical company utili...op compounds that promote the growth of new neuron...) diseases, announced today that it has,initiated ...ndidate,BCI-540, for the treatment of depression w...m expressed by our clinical,investigators who view...
...f Company,s Phase 3 Study for Wet AMD after ...ONT, Calif., April 17 NeoVista, Inc. announced,to...A) has granted the,company,s request to expand the...e 3 trial from 10 to 30 in the United States. The ...MD Treated with BEta RadiatioN,Epiretinal Therapy)...
Other Medicine Technology:BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 3
Tumbling E Pad(100 sheets) BCE
...riced 2-channel data acquisition system suitable f...n and animal physiology, pharmacology, neurophysio...l engineering. The PowerLab 2/25 supports all ADIn... Pod ports are featured allowing direct connection...
... data acquisition system suitable for a wide range...al physiology, pharmacology, neurophysiology, biol...ring. The unit is capable of recording from very s... second continuously to disk), and is compatible w...
Worth 4 Dot Test
Medicine Products: